Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Identifying the needs of penile cancer sufferers: A systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer

Identifieur interne : 001B34 ( Pmc/Curation ); précédent : 001B33; suivant : 001B35

Identifying the needs of penile cancer sufferers: A systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer

Auteurs : Satish B. Maddineni [Royaume-Uni] ; Maurice M. Lau [Royaume-Uni] ; Vijay K. Sangar [Royaume-Uni]

Source :

RBID : PMC:2731105

Abstract

Background

Penile cancer is an uncommon malignancy with an incidence of 1 per 100,000. Conservative and radical treatments can be disfiguring and may have an impact on sexual function, quality of life (QOL), social interactions, self-image and self-esteem. Knowledge of how this disease affects patients is paramount to developing a global, multi-disciplinary approach to treatment.

Methods

A Medline/PubMed literature search was conducted using the terms "sexual function penis cancer"; "quality of life penis cancer" and "psychological effects penis cancer" from 1985 to 2008. Articles containing quantitative data on QOL, sexual function or psychological well-being were included.

Results

128 patients from 6 studies were included. 5 studies contained retrospective data whilst 1 study collected prospective data on erectile function. In the 6 studies 13 different quantitative tools were used to assess psychological well-being, QOL and sexual function. The General Health Questionnaire (GHQ) showed impaired well-being in up to 40% in 2 studies. Patients undergoing more mutilating treatments were more likely to have impaired well-being. The Hospital Anxiety and Depression Score (HADS) demonstrated pathological anxiety up to 31% in 2 studies. 1 study used the Diagnostic and Statistical Manual of Mental Disorders of psychiatric illness (DSM III-R) with 53% exhibiting mental illness, 25% avoidance behaviour and 40% impaired well-being. 12/30 suffered from post-traumatic stress disorder. The IIEF-15 was the commonest tool used to assess sexual function. The results varied from 36% in 1 study with no sexual function to 67% in another reporting reduced sexual satisfaction to 78% in another reporting high confidence with erections.

Conclusion

The treatment of penile cancer results in negative effects on well-being in up to 40% with psychiatric symptoms in approximately 50%. Up to two-thirds of patients report a reduction in sexual function. This study demonstrates that penile cancer sufferers can exhibit significant psychological dysfunction, yet no standardised tools or interventional pathways are available. Therefore, there is a need to identify and assess adequate tools to measure psychological and sexual dysfunction in this group of patients.


Url:
DOI: 10.1186/1471-2490-9-8
PubMed: 19664235
PubMed Central: 2731105

Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:2731105

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Identifying the needs of penile cancer sufferers: A systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer</title>
<author>
<name sortKey="Maddineni, Satish B" sort="Maddineni, Satish B" uniqKey="Maddineni S" first="Satish B" last="Maddineni">Satish B. Maddineni</name>
<affiliation wicri:level="1">
<nlm:aff id="I1">Department of Urology, The Christie Hospital, Manchester, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Urology, The Christie Hospital, Manchester</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Lau, Maurice M" sort="Lau, Maurice M" uniqKey="Lau M" first="Maurice M" last="Lau">Maurice M. Lau</name>
<affiliation wicri:level="1">
<nlm:aff id="I1">Department of Urology, The Christie Hospital, Manchester, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Urology, The Christie Hospital, Manchester</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Sangar, Vijay K" sort="Sangar, Vijay K" uniqKey="Sangar V" first="Vijay K" last="Sangar">Vijay K. Sangar</name>
<affiliation wicri:level="1">
<nlm:aff id="I1">Department of Urology, The Christie Hospital, Manchester, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Urology, The Christie Hospital, Manchester</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="I2">Department of Urology, University Hospital of South Manchester, Manchester, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Urology, University Hospital of South Manchester, Manchester</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="I3">Division of Cancer Studies & Imaging, University of Manchester, Manchester, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Cancer Studies & Imaging, University of Manchester, Manchester</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">19664235</idno>
<idno type="pmc">2731105</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731105</idno>
<idno type="RBID">PMC:2731105</idno>
<idno type="doi">10.1186/1471-2490-9-8</idno>
<date when="2009">2009</date>
<idno type="wicri:Area/Pmc/Corpus">001B35</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001B35</idno>
<idno type="wicri:Area/Pmc/Curation">001B34</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001B34</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Identifying the needs of penile cancer sufferers: A systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer</title>
<author>
<name sortKey="Maddineni, Satish B" sort="Maddineni, Satish B" uniqKey="Maddineni S" first="Satish B" last="Maddineni">Satish B. Maddineni</name>
<affiliation wicri:level="1">
<nlm:aff id="I1">Department of Urology, The Christie Hospital, Manchester, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Urology, The Christie Hospital, Manchester</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Lau, Maurice M" sort="Lau, Maurice M" uniqKey="Lau M" first="Maurice M" last="Lau">Maurice M. Lau</name>
<affiliation wicri:level="1">
<nlm:aff id="I1">Department of Urology, The Christie Hospital, Manchester, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Urology, The Christie Hospital, Manchester</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Sangar, Vijay K" sort="Sangar, Vijay K" uniqKey="Sangar V" first="Vijay K" last="Sangar">Vijay K. Sangar</name>
<affiliation wicri:level="1">
<nlm:aff id="I1">Department of Urology, The Christie Hospital, Manchester, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Urology, The Christie Hospital, Manchester</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="I2">Department of Urology, University Hospital of South Manchester, Manchester, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Urology, University Hospital of South Manchester, Manchester</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="I3">Division of Cancer Studies & Imaging, University of Manchester, Manchester, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Cancer Studies & Imaging, University of Manchester, Manchester</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">BMC Urology</title>
<idno type="eISSN">1471-2490</idno>
<imprint>
<date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<sec>
<title>Background</title>
<p>Penile cancer is an uncommon malignancy with an incidence of 1 per 100,000. Conservative and radical treatments can be disfiguring and may have an impact on sexual function, quality of life (QOL), social interactions, self-image and self-esteem. Knowledge of how this disease affects patients is paramount to developing a global, multi-disciplinary approach to treatment.</p>
</sec>
<sec sec-type="methods">
<title>Methods</title>
<p>A Medline/PubMed literature search was conducted using the terms "sexual function penis cancer"; "quality of life penis cancer" and "psychological effects penis cancer" from 1985 to 2008. Articles containing quantitative data on QOL, sexual function or psychological well-being were included.</p>
</sec>
<sec>
<title>Results</title>
<p>128 patients from 6 studies were included. 5 studies contained retrospective data whilst 1 study collected prospective data on erectile function. In the 6 studies 13 different quantitative tools were used to assess psychological well-being, QOL and sexual function. The General Health Questionnaire (GHQ) showed impaired well-being in up to 40% in 2 studies. Patients undergoing more mutilating treatments were more likely to have impaired well-being. The Hospital Anxiety and Depression Score (HADS) demonstrated pathological anxiety up to 31% in 2 studies. 1 study used the Diagnostic and Statistical Manual of Mental Disorders of psychiatric illness (DSM III-R) with 53% exhibiting mental illness, 25% avoidance behaviour and 40% impaired well-being. 12/30 suffered from post-traumatic stress disorder. The IIEF-15 was the commonest tool used to assess sexual function. The results varied from 36% in 1 study with no sexual function to 67% in another reporting reduced sexual satisfaction to 78% in another reporting high confidence with erections.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>The treatment of penile cancer results in negative effects on well-being in up to 40% with psychiatric symptoms in approximately 50%. Up to two-thirds of patients report a reduction in sexual function. This study demonstrates that penile cancer sufferers can exhibit significant psychological dysfunction, yet no standardised tools or interventional pathways are available. Therefore, there is a need to identify and assess adequate tools to measure psychological and sexual dysfunction in this group of patients.</p>
</sec>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="research-article">
<pmc-dir>properties open_access</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">BMC Urol</journal-id>
<journal-title>BMC Urology</journal-title>
<issn pub-type="epub">1471-2490</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">19664235</article-id>
<article-id pub-id-type="pmc">2731105</article-id>
<article-id pub-id-type="publisher-id">1471-2490-9-8</article-id>
<article-id pub-id-type="doi">10.1186/1471-2490-9-8</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Identifying the needs of penile cancer sufferers: A systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer</article-title>
</title-group>
<contrib-group>
<contrib id="A1" contrib-type="author">
<name>
<surname>Maddineni</surname>
<given-names>Satish B</given-names>
</name>
<xref ref-type="aff" rid="I1">1</xref>
<email>satishandsian@yahoo.co.uk</email>
</contrib>
<contrib id="A2" contrib-type="author">
<name>
<surname>Lau</surname>
<given-names>Maurice M</given-names>
</name>
<xref ref-type="aff" rid="I1">1</xref>
<email>Maurice.Lau@christie.nhs.uk</email>
</contrib>
<contrib id="A3" corresp="yes" contrib-type="author">
<name>
<surname>Sangar</surname>
<given-names>Vijay K</given-names>
</name>
<xref ref-type="aff" rid="I1">1</xref>
<xref ref-type="aff" rid="I2">2</xref>
<xref ref-type="aff" rid="I3">3</xref>
<email>vijay.sangar@nhs.net</email>
</contrib>
</contrib-group>
<aff id="I1">
<label>1</label>
Department of Urology, The Christie Hospital, Manchester, UK</aff>
<aff id="I2">
<label>2</label>
Department of Urology, University Hospital of South Manchester, Manchester, UK</aff>
<aff id="I3">
<label>3</label>
Division of Cancer Studies & Imaging, University of Manchester, Manchester, UK</aff>
<pub-date pub-type="collection">
<year>2009</year>
</pub-date>
<pub-date pub-type="epub">
<day>8</day>
<month>8</month>
<year>2009</year>
</pub-date>
<volume>9</volume>
<fpage>8</fpage>
<lpage>8</lpage>
<ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2490/9/8"></ext-link>
<history>
<date date-type="received">
<day>18</day>
<month>2</month>
<year>2009</year>
</date>
<date date-type="accepted">
<day>8</day>
<month>8</month>
<year>2009</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2009 Maddineni et al; licensee BioMed Central Ltd.</copyright-statement>
<copyright-year>2009</copyright-year>
<copyright-holder>Maddineni et al; licensee BioMed Central Ltd.</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
<p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (
<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"></ext-link>
), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
<pmc-comment> Maddineni B Satish satishandsian@yahoo.co.uk Identifying the needs of penile cancer sufferers: A systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer 2009BMC Urology 9(1): 8-. (2009)1471-2490(2009)9:1<8>urn:ISSN:1471-2490</pmc-comment>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Penile cancer is an uncommon malignancy with an incidence of 1 per 100,000. Conservative and radical treatments can be disfiguring and may have an impact on sexual function, quality of life (QOL), social interactions, self-image and self-esteem. Knowledge of how this disease affects patients is paramount to developing a global, multi-disciplinary approach to treatment.</p>
</sec>
<sec sec-type="methods">
<title>Methods</title>
<p>A Medline/PubMed literature search was conducted using the terms "sexual function penis cancer"; "quality of life penis cancer" and "psychological effects penis cancer" from 1985 to 2008. Articles containing quantitative data on QOL, sexual function or psychological well-being were included.</p>
</sec>
<sec>
<title>Results</title>
<p>128 patients from 6 studies were included. 5 studies contained retrospective data whilst 1 study collected prospective data on erectile function. In the 6 studies 13 different quantitative tools were used to assess psychological well-being, QOL and sexual function. The General Health Questionnaire (GHQ) showed impaired well-being in up to 40% in 2 studies. Patients undergoing more mutilating treatments were more likely to have impaired well-being. The Hospital Anxiety and Depression Score (HADS) demonstrated pathological anxiety up to 31% in 2 studies. 1 study used the Diagnostic and Statistical Manual of Mental Disorders of psychiatric illness (DSM III-R) with 53% exhibiting mental illness, 25% avoidance behaviour and 40% impaired well-being. 12/30 suffered from post-traumatic stress disorder. The IIEF-15 was the commonest tool used to assess sexual function. The results varied from 36% in 1 study with no sexual function to 67% in another reporting reduced sexual satisfaction to 78% in another reporting high confidence with erections.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>The treatment of penile cancer results in negative effects on well-being in up to 40% with psychiatric symptoms in approximately 50%. Up to two-thirds of patients report a reduction in sexual function. This study demonstrates that penile cancer sufferers can exhibit significant psychological dysfunction, yet no standardised tools or interventional pathways are available. Therefore, there is a need to identify and assess adequate tools to measure psychological and sexual dysfunction in this group of patients.</p>
</sec>
</abstract>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B34 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 001B34 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Pmc
   |étape=   Curation
   |type=    RBID
   |clé=     PMC:2731105
   |texte=   Identifying the needs of penile cancer sufferers: A systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i   -Sk "pubmed:19664235" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024